Alzheimer's disease trials recruiting in Minnesota

All Alzheimer's disease trials nationally

Cities in Minnesota

Recruiting trials in Minnesota

• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
  NCT07011745 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Minnesota: Saint Paul
• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
  NCT07589595 · Phase: Phase 2 · Ages: 55 Years to 85 Years · Sex: All (male and female) · Minnesota: Golden Valley, Rochester
• A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
  NCT06976216 · Phase: Phase 3 · Ages: 60 Years to 85 Years · Sex: All (male and female) · Minnesota: Saint Paul
• A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
  NCT06937229 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Minnesota: Saint Paul
• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
  NCT06563895 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Minnesota: Rochester
• Late Onset Alzheimer's Disease
  NCT05010603 · Phase: Not specified · Ages: 55 Years and older · Sex: All (male and female) · Minnesota: Rochester
• MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics
  NCT04099823 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Rochester
• Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
  NCT02740634 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 80 Years · Sex: All (male and female) · Minnesota: Rochester
• PROMIS and Mobility Evaluation in Sarcoma Patients
  NCT07227961 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Rochester
• Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
  NCT03821857 · Phase: Phase 4 · Ages: 60 Years and older · Sex: Female · Minnesota: Rochester